Product correctly added to cart.

discount label
SW155246
View 3D

Biosynth logo

SW155246

CAS: 420092-79-1

Ref. 3D-VRA09279

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Wednesday 26 Jun 2024

Product Information

Name:
SW155246
Description:

SW155246 is a molecule that inhibits the activity of DNA methyltransferase (DNMT), an enzyme that catalyzes the transfer of methyl groups to cytosine residues. This inhibition leads to hypomethylation, which can result in transcriptional changes and cancer cell death. SW155246 has been shown to be a potent inhibitor of DNMT in vitro and also induces apoptosis in cancer cells. This drug has been shown to inhibit the expression of genes involved in DNA repair, such as catalase, which may be responsible for its anticancer effects.

Rifapentine is an anti-tuberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. The high frequency of human activity has been shown using a patch-clamp technique on

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
378.79 g/mol
Formula:
C16H11ClN2O5S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-VRA09279 SW155246

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".